Cristina Vilaplana

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbués, Jesús Gonzalo‐Asensio, Dessislava Marinova et al. · Vaccine · 2013 · 258 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

Lúcia Moreira-Teixeira, Philippa J. Stimpson, Evangelos Stavropoulos et al. · Nature Communications · 2020 · 236 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis

Cristina Vilaplana, Elena Marzo, Gustavo Tapia et al. · The Journal of Infectious Diseases · 2013 · 216 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®

Cristina Vilaplana, Eva Montané, Sergio Pinto et al. · Vaccine · 2009 · 129 citations

Veterinary Medicine, Immunology, Pharmacotherapy +13

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Marco Schito, Giovanni Battista Migliori, Helen A. Fletcher et al. · Clinical Infectious Diseases · 2015 · 125 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17